APA

Hari P., Mateos M., Abonour R., Knop S., Bensinger W., Ludwig H., Song K., Hajek R., Moreau P., Siegel D. S., Feng S., Obreja M., Aggarwal S. K., Iskander K. & Goldschmidt H. (20171215). Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes. : Leukemia.

Chicago

Hari P, Mateos M-V, Abonour R, Knop S, Bensinger W, Ludwig H, Song K, Hajek R, Moreau P, Siegel D S, Feng S, Obreja M, Aggarwal S K, Iskander K and Goldschmidt H. 20171215. Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes. : Leukemia.

Harvard

Hari P., Mateos M., Abonour R., Knop S., Bensinger W., Ludwig H., Song K., Hajek R., Moreau P., Siegel D. S., Feng S., Obreja M., Aggarwal S. K., Iskander K. and Goldschmidt H. (20171215). Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes. : Leukemia.

MLA

Hari P, Mateos M-V, Abonour R, Knop S, Bensinger W, Ludwig H, Song K, Hajek R, Moreau P, Siegel D S, Feng S, Obreja M, Aggarwal S K, Iskander K and Goldschmidt H. Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes. : Leukemia. 20171215.